Delivery Order SPE2DB22D1202-SPE2DB24FVGZ7
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, a critical pharmaceutical product to support military and federal healthcare needs. The contract has a ceiling value of $19,303.00 and is a firm fixed-price delivery order, with an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of RABAVERT rabies vaccine with diluents. The contract has a period of performance through September 30, 2024 and a ceiling value of $33,832.46. It is a firm fixed price contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medical commodities, including prescription drugs, vaccines, and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $30,347.45 and a period of performance through August 16, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite-delivery contracts (IDCs) by the DLA and other federal agencies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,871.32 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of September 16, 2024. It does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, is a supplier of a wide range of prescription medications, over-the-counter drugs,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $19,741.08 and a period of performance through October 9, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,621.43 firm fixed-price contract is for the supply of RABAVERT Rabies Vaccine with Diluents. The order has a completion date of September 6, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a ceiling value of $10,479.00 and a period of performance running through January 22, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,239.50, is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,790.90 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT rabies vaccine with diluents, with a ceiling value of $1,105.74 and a completion date of June 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...